SEC Form 4 · accession 0001104659-26-091279
Nuvectis Pharma, Inc. · NVCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Carson
Officer — Vice President, Finance
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 5:26 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001875558
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 3, 2026 | A | 30,000 | $0.00 | A | 230,118 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The 30,000 shares of restricted common stock will fully vest on August 3, 2027, subject to Mr. Carson's continued service on such date.
- F2Includes shares of restricted common stock.